Investors & News Elli Park 12/26/23 Elli Park 12/26/23 The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation - ScienceDirect Read More Veronica Oronos 4/24/23 Veronica Oronos 4/24/23 Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan Patients Read More Veronica Oronos 2/20/23 Veronica Oronos 2/20/23 Mezzion Pharma Submits Protocol for Confirmatory Pivotal Phase 3 Trial ("FUEL-2") in Fontan Subjects Read More Veronica Oronos 5/30/22 Veronica Oronos 5/30/22 Mezzion Pharma Receives Clear FDA Path Forward for the Approval of Udenafil for Single Ventricle Heart Disease Read More
Elli Park 12/26/23 Elli Park 12/26/23 The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation - ScienceDirect Read More
Veronica Oronos 4/24/23 Veronica Oronos 4/24/23 Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan Patients Read More
Veronica Oronos 2/20/23 Veronica Oronos 2/20/23 Mezzion Pharma Submits Protocol for Confirmatory Pivotal Phase 3 Trial ("FUEL-2") in Fontan Subjects Read More
Veronica Oronos 5/30/22 Veronica Oronos 5/30/22 Mezzion Pharma Receives Clear FDA Path Forward for the Approval of Udenafil for Single Ventricle Heart Disease Read More
